Aemetis (NASDAQ:AMTX) Posts Earnings Results, Beats Estimates By $0.04 EPS

Aemetis (NASDAQ:AMTX) released its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.28) by $0.04, Zacks reports. The firm had revenue of $43.31 million during the quarter, compared to the consensus estimate of $72.07 million.

Here are the key takeaways from Aemetis’ conference call:

• Aemetis’ dairy RNG segment reached positive segment net income and EBITDA in Q4, produced ~405,000 MMBtus in 2025 (12 digesters) with Q4 biogas net income of $12.2M and 61% production growth, and management expects strong cash-flow growth over the next four years as expansion and 45Z monetization proceed.
• The Keyes ethanol plant’s mechanical vapor recompression (MVR) upgrade — already >50% spent and fully financed — is projected to cut natural gas use ~80%, lower carbon intensity, and add roughly $32 million of annual plant cash flow with contributions beginning in Q3–Q4 2026.
• Policy and credit tailwinds are strengthening revenue visibility: LCFS credit prices have risen ~60% recently and the February 4 Treasury guidance on Section 45Z positions the company to capture additional production tax credits once the DOE’s GREET spreadsheet and calculated emissions value letters are issued.
• Capital plan: MVR and a $27M H2S contract are fully financed, while management expects roughly $70M more for digester build-out (overlapping into 2027) and plans to use long‑term (20‑year) project financings for further expansion.
• The India subsidiary generated $29.7M in 2025 revenue with ~80M gallon biodiesel capacity and management is pursuing an IPO to fund expansion into CBG and sustainable aviation fuel, though market timing and execution remain uncertain.

Aemetis Price Performance

NASDAQ:AMTX traded up $0.12 during mid-day trading on Friday, reaching $2.04. 1,380,746 shares of the company’s stock traded hands, compared to its average volume of 890,586. The company has a 50 day moving average price of $1.54 and a 200-day moving average price of $1.91. The firm has a market capitalization of $134.72 million, a price-to-earnings ratio of -1.26 and a beta of 2.61. Aemetis has a 12-month low of $1.22 and a 12-month high of $3.66.

Institutional Investors Weigh In On Aemetis

Institutional investors and hedge funds have recently modified their holdings of the stock. Creative Planning purchased a new position in Aemetis in the second quarter worth about $30,000. Engineers Gate Manager LP purchased a new position in shares of Aemetis in the second quarter worth $42,000. Centiva Capital LP purchased a new position in Aemetis in the 3rd quarter worth about $39,000. Virtu Financial LLC bought a new position in Aemetis during the fourth quarter valued at approximately $31,000. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Aemetis by 206.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 22,962 shares of the specialty chemicals company’s stock valued at $57,000 after buying an additional 15,474 shares during the period. 27.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AMTX has been the topic of a number of research analyst reports. Loop Capital set a $1.75 target price on Aemetis in a research note on Thursday. Ascendiant Capital Markets lowered their target price on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 19th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $13.19.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.